View Mobile Friendly Conference List »

Global Clinical Trials 2013

GCT Speaker, Dan McDonald, DAC Patient Recruitment Services featured on Clinical Leader

Dan McDonald has been around global trials for more than 14 years, spending considerable time traveling internationally and working for US and Asian based clinical research organizations. In his current role as director of business development for DAC Patient Recruitment Services, he works with biopharmaceutical companies to develop and execute customized strategies for their site […]

Read More »

Free Seminar for Biotech Companies on Getting your Biologic / NCE Drug Ready for the EU

Our speaker and friend, Dr Thomas Lonngren former head of EMA will lead a free morning seminar for biotech companies on Thursday, November 6th in Boston on how to prepare your biologic/NCE drug for the EU. For more information, click the link below: http://www.thehivedev.co.uk/nda-emails/massbio-tl-2.html

Read More »

Medtech Boston talks with Valerie Bowling about Conference Forum events

If you’re interested in disruptive innovations in clinical trials or drug delivery, Boston is prime real-estate. That’s why The Conference Forum will be hosting four major events in September and October 2014: Mobile and Clinical Trials; Global Clinical Trials; DPharm: Disruptive Innovations to Advance Clinical Trials; and Partnerships in Drug Delivery. We caught up with […]

Read More »

Speakers Recognized by PharmaVoice100

PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life-sciences industry. These people actively demonstrate what it means to think bigger and lead with passion and integrity. They are nominated by thousands of PharmaVOICE readers throughout the year. We are so pleased to see several of our speakers make […]

Read More »

The Biggest Challenges in Conducting Global Clinical Trials

The Biggest Challenges in Conducting Global Clinical Trials By Chris Gallen Trials have to test the hypothesis that the treatment differs from placebo or another treatment. To do that you have to compare results from the groups. The key to your ability to do so is the variance between the groups. If you have two […]

Read More »

Former Head, EMA, Dr Thomas Lonngren Shares his View on US Payers and the Increasing Cost of New Drugs

In May, I was invited to speak at the Chief Medical Officer Summit in Boston, attended by chief medical and scientific officers from US biotech companies. In my speech, I covered the EU regulatory framework and new developments. This included raising the discussion of the increasing demand from EU payers to demonstrate the cost effectiveness […]

Read More »

Making Global Clinical Trials Easier for Patients & for Sites at the 5th Annual Global Clinical Trials Conference

The Executing Global Clinical Trials conference announced today that the voice of the patient in shaping global clinical trials is central to the 5th annual event. “Making global trials easier for patients and sites is critical to the future of drug development,” says, Kristen Pisanelli, Conference Producer. Harvard Global Health Institute, NPS Pharma, and Bayer […]

Read More »

A Peek at GCT 2012

Presentation from 3rd Annual Executing Global Clinical Trials conference, Boston, MA September 2012 from Eileen Daniel, Director, Clinical & Data Operations, Endo Pharmaceuticals

Read More »

A Peek at GCT 2012

Presentation from 3rd Annual Executing Global Clinical Trials conference, Boston, MA September 2012 from Mitchell Katz, Ph.D. Executive Director, Medical Research Operations Purdue Pharma L.P. A Peek at GCT 2012 from ConferenceForum

Read More »

A Peek at GCT 2012

Keynote Presentation from 3rd Annual Executing Global Clinical Trials conference, Boston, MA Septemvber 2012 on Emerging Markets by Novartis; Regional Medical Director, OTC, GEM, Helmut Wolf, MD

Read More »